| Literature DB >> 26264009 |
Harun R Gungor1, Semih Akkaya2, Nusret Ok3, Aygun Yorukoglu4, Cagdas Yorukoglu5, Esat Kiter6, Emin O Oguz7, Nazan Keskin8, Gulcin A Mete9.
Abstract
Technicians often receive chronic magnetic exposures from magnetic resonance imaging (MRI) devices, mainly due to static magnetic fields (SMFs). Here, we ascertain the biological effects of chronic exposure to SMFs from MRI devices on the bone quality using rats exposed to SMFs in MRI examining rooms. Eighteen Wistar albino male rats were randomly assigned to SMF exposure (A), sham (B), and control (C) groups. Group A rats were positioned within 50 centimeters of the bore of the magnet of 1.5 T MRI machine during the nighttime for 8 weeks. We collected blood samples for biochemical analysis, and bone tissue samples for electron microscopic and histological analysis. The mean vitamin D level in Group A was lower than in the other groups (p = 0.002). The mean cortical thickness, the mean trabecular wall thickness, and number of trabeculae per 1 mm2 were significantly lower in Group A (p = 0.003). TUNEL assay revealed that apoptosis of osteocytes were significantly greater in Group A than the other groups (p = 0.005). The effect of SMFs in chronic exposure is related to movement within the magnetic field that induces low-frequency fields within the tissues. These fields can exceed the exposure limits necessary to deteriorate bone microstructure and vitamin D metabolism.Entities:
Keywords: Static magnetic field; bone; chronic exposure; magnetic resonance imaging; osteoporosis; vitamin D
Mesh:
Year: 2015 PMID: 26264009 PMCID: PMC4555256 DOI: 10.3390/ijerph120808919
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Measurement of cortical bone thickness (at 300× magnification) on the FESEM image (specimen from Group A).
Figure 2Measurement of trabecular bone thickness and determination of number of trabeculae (on a chart area of approximately 878 × 1250 µm2 at 4× magnification) on the histologic specimen (specimen from Group A).
Mean values and standard deviations of measured variables.
| Measured Variables | Group A | Group B | Group C | |
|---|---|---|---|---|
| (Mean ± SD) | (Mean ± SD) | (Mean ± SD) | ||
| (Min–Max) | (Min–Max) | (Min–Max) | ||
| Vitamin D (pg/mL) | 38.7 ± 20.2 | 97.5 ± 10.2 | 82.2 ± 13.8 | 0.002 |
| (17.4–73.2) | (78.6–109.7) | (64.6–95.7) | ||
| A. phosphatase (mIU/mL) | 1 ± 0.97 | 0.9 ± 0.2 | 0.8 ± 0.2 | n.s |
| (0.12–3.11) | (0.4–1.5) | (0.5–1) | ||
| Calcium ( mg/dL) | 8.9 ± 0.7 | 9 ± 0.2 | 9 ± 0.7 | n.s |
| (7.8–9.7) | (8.7–9.1) | (7.8–9.9) | ||
| Phosphorus (mg/dL) | 7.4 ± 0.8 | 7.1 ± 0.6 | 7.3 ± 1.3 | n.s |
| (6.4–8.5) | (6.3–7.7) | (6.1–9.6) | ||
| Cortical thickness (µm) | 156.9 ± 30.4 | 254.9 ± 27.7 | 293.7 ± 26.6 | 0.001 |
| (103.6–186.8) | (224–283.8) | (262.8–327.2) | ||
| Trabecular thickness (µm) | 39.7 ± 4.1 | 60.1 ± 8.7 | 61 ± 8.3 | 0.003 |
| (10.6–22.9) | (51.1–71.5) | (50.2–72.4) | ||
| Trabeculae n/mm2 | 4.4 ± 0.5 | 5.6 ± 0.3 | 5.6 ± 0.4 | 0.003 |
| (3.7–4.9) | (5.3–6) | (5.2–6.1) | ||
| Apoptotosis (%) | 41.1 ± 2.8 | 26.4 ± 4.7 | 4.1 ± 1.8 | 0.005 |
| (37.8–44.1) | (20.3–32.1) | (1.8–6.1) |
Figure 3TEM evaluation of Group C; (a) Osteocyte within lacunae (black arrow) and cytoplasmic extensions (black and white arrow), N refers to nucleus (at 15K×); (b) Osteocyte (black arrow), M refers to mitochondria (at 135K×).
Figure 4TEM evaluation of Group B (a) Osteocyte (arrow; N refers to nucleus; at 21K×); (b) Granular endoplasmic reticulum (ER), mitochondria (M), golgi complex (GC; at 83K×).
Figure 5TEM evaluation of Group A (a) Heterochromatic osteocyte (black arrow), decreased and condensed cytoplasm with round appearances (white arrow; at 26K×); (b) Round appearances within cytoplasm (white arrow), mitochondria (M) and nucleus (N; at 56K×).
Figure 6Hematoxylin and eosin staining of bone sections of left femur subcapital region; (a) In Group A, trabecular walls are thinner than in other groups (b) Group B; (c) Group C (10×).
Figure 7Tunnel assay, arrows point apoptotic cells (a) Group A; (b) Group B; (c) Group C (at 20×).